small bowel

小肠
  • 文章类型: Journal Article
    本研究评估了急性小肠出血(SBB)患者经导管动脉栓塞(TAE)的技术和临床结果,并旨在确定TAE后早期复发性出血的潜在危险因素。
    纳入了在2006年1月至2021年12月期间接受TAE治疗的31例SBB患者。技术和临床成功定义为出血动脉的血管造影闭塞和持续出血的临床或实验室体征消失,无重大并发症。根据介入放射学协会的指南对并发症进行分类。Kaplan-Meier估计评估了总生存率,和logistic回归模型确定了临床成功和早期再出血的危险因素.
    在30/31(97%)和19(61%)中取得了技术和临床成功,分别。9例(29%)患者出现早期复发性出血,并对4例患者进行了重复栓塞治疗,4例患者转换为手术,1例患者接受舒适治疗。在2例(6.5%)患者中发现了需要手术的TAE相关小肠缺血。30天和住院死亡率分别为19%(6/31)和23%(7/31),5年总生存率分别为60%.TAE前血小板减少和凝血酶原时间(PT)/活化部分凝血活酶时间(aPTT)水平升高被确定为临床失败的危险因素(分别为P=0.0026和P=0.027),以及残余或早期复发性出血(分别为P<0.001和P=0.01)。
    TAE对于管理严重的SBB是安全有效的;但是,近三分之一的患者发现早期复发性出血。血小板减少和PT/aPTT水平升高是早期复发性出血的危险因素。
    UNASSIGNED: This study evaluated the technical and clinical outcomes of transcatheter arterial embolization (TAE) in patients with acute small-bowel bleeding (SBB) and aimed to identify potential risk factors for early recurrent bleeding after TAE.
    UNASSIGNED: Thirty-one patients with SBB managed with TAE between January 2006 and December 2021 were included. Technical and clinical success was defined as angiographic occlusion of the bleeding artery and disappearance of clinical or laboratory signs of persistent bleeding without major complications. Complications were classified according to the Society of Interventional Radiology\'s guidelines. Kaplan-Meier estimates assessed overall survival, and logistic regression models determined risk factors for clinical success and early rebleeding.
    UNASSIGNED: Technical and clinical success were achieved in 30/31 (97%) and 19 (61%), respectively. Early recurrent bleeding was present in 9 (29%) patients, and was treated by repeat embolization in 4 patients, conversion to surgery in 4, and comfort therapy in 1 patient. TAE-related small bowel ischemia requiring surgery was found in 2 (6.5%) patients. Thirty-day and in-hospital mortality were 19% (6/31) and 23% (7/31), respectively; overall 5-year estimated survival was 60%. Thrombocytopenia and elevated prothrombin time (PT)/activated partial thromboplastin time (aPTT) levels prior to TAE were identified as risk factors for clinical failure (P=0.0026 and P=0.027, respectively), and for residual or early recurrent bleeding (P<0.001 and P=0.01, respectively).
    UNASSIGNED: TAE is safe and effective for managing severe SBB; however, early recurrent bleeding was found in nearly one third of patients. Thrombocytopenia and elevated PT/aPTT levels were risk factors for early recurrent bleeding.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    克罗恩病(CD)是一种慢性炎症性肠病(IBD),经常影响小肠。与普通人群相比,被诊断患有CD的个体患肠癌的风险增加。小肠癌是一种罕见但显著的CD并发症。腺癌是这些肿瘤中最常见的,其次是神经内分泌肿瘤和肉瘤。确定的主要危险因素是男性,疾病持续时间,以前的手术干预,肛周疾病,慢性炎症。确切的病因仍不清楚。另一个关键问题涉及免疫调节剂和先进疗法的作用。通过抑制炎症,这些疗法可以降低患癌症的风险,这通常是由炎症-发育不良-腺癌序列引发的。根据最新的指导方针,没有必要对CD患者中的小肠癌患者进行监测,因为它被认为是一种罕见的疾病。然而,对于胃肠病学家来说,意识到这种潜在的CD并发症非常重要,以及最有发展风险的患者。这篇综述的目的是提供CD-SBC的全面概述,专注于流行病学,病因,危险因素,诊断,以及先进疗法在CD-SBC中的作用。
    Crohn\'s disease (CD) is a chronic inflammatory bowel disease (IBD) that frequently affects the small bowel. Individuals diagnosed with CD are at increased risk of developing bowel cancer compared to the general population. Small bowel cancer is a rare but significant CD complication. Adenocarcinoma represents the most prevalent of these neoplasms, followed by neuroendocrine tumors and sarcomas. The primary risk factors identified are being of the male sex, disease duration, previous surgical intervention, perianal disease, and chronic inflammation. The precise etiology remains unclear. Another crucial issue concerns the role of immunomodulators and advanced therapies. By inhibiting inflammation, these therapies can reduce the risk of cancer, which is often initiated by the inflammation-dysplasia-adenocarcinoma sequence. In accordance with the most recent guidelines, it is not necessary to conduct surveillance in patients with small bowel cancer among CD patients, as it is considered a rare disease. Nevertheless, it is of significant importance for gastroenterologists to be aware of this potential CD complication, as well as the patients who are most at risk of developing it. The purpose of this review is to provide a comprehensive overview of CD-SBC, focusing on epidemiology, etiopathogenesis, risk factors, diagnosis, and the role of advanced therapies in CD-SBC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    虽然肠梗阻是最常见的小肠外科疾病,Meckel憩室引起的小肠梗阻是相对罕见的。我们遇到了一个令人信服的小肠梗阻病例,结果比预期的要复杂得多,涉及Meckel的憩室,并有一些不可预见的发现。我们遵循了记录历史的标准准则,考试,调查,和肠梗阻的管理。在用尽保守治疗方案后,我们选择了外科手术,阻塞的意外原因让我们大吃一惊。此病例报告强调了一种极为罕见的实体:Meckel憩室引起的罕见并发症。
    While bowel obstruction is the most common surgical disorder of the small intestine, small bowel obstruction due to Meckel\'s diverticulum is a relatively rare occurrence. We encountered a compelling case of small bowel obstruction that turned out to be more complex than anticipated, involving a Meckel\'s diverticulum with some unforeseen findings. We followed standard guidelines for history-taking, examination, investigations, and management of the intestinal obstruction. After exhausting conservative treatment options, we opted for surgical intervention, and the unexpected cause of the obstruction took us by surprise. This case report highlights an exceedingly rare entity: Meckel\'s diverticulum precipitating uncommon complications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    小肠神经内分泌肿瘤(NETs)是罕见的,但由于其具有挑战性的诊断途径和潜在的潜在进展,具有临床意义。在这些情况下,早期识别对于有效治疗和改善预后至关重要。
    方法:这里,我们介绍了一例没有明显病史的75岁患者,其急性表现为弥漫性腹痛,呕吐,和肠梗阻的迹象.诊断检查,包括CT成像,显示回肠远端神经内分泌肿块伴肠系膜淋巴结肿大,需要紧急手术干预。
    结论:该病例强调了与小肠NET相关的诊断复杂性和治疗挑战。手术切除和细致的淋巴结清扫仍然是治疗的基石,旨在实现完整的肿瘤切除和最佳的疾病控制。考虑到患者的临床过程,讨论了成像方式和生化标志物在指导临床决策和术后管理策略中的作用。
    结论:及时识别和干预在小肠NET的管理中至关重要,考虑到他们可能出现迟发症状和非特异性症状。尽管在这种情况下强调了诊断和程序上的挑战,对于小肠NETs患者,早期手术干预和全面随访是取得良好结局和将复发风险降至最低的关键.
    UNASSIGNED: Neuroendocrine tumors (NETs) of the small bowel are rare but clinically significant due to their challenging diagnostic pathways and potential for insidious progression. Early identification is critical for effective management and improved prognosis in these cases.
    METHODS: Here, we present a case of a 75-year-old patient with no significant medical history who presented acutely with diffuse abdominal pain, vomiting, and signs of bowel obstruction. Diagnostic workup, including CT imaging, revealed a distal ileal neuroendocrine mass with mesenteric lymphadenopathy, necessitating urgent surgical intervention.
    CONCLUSIONS: This case underscores the diagnostic complexities and therapeutic challenges associated with small bowel NETs. Surgical resection with meticulous lymph node dissection remains the cornerstone of treatment, aimed at achieving complete tumor excision and optimal disease control. The role of imaging modalities and biochemical markers in guiding clinical decisions and postoperative management strategies is discussed considering the patient\'s clinical course.
    CONCLUSIONS: Timely recognition and intervention are crucial in the management of small bowel NETs, given their potential for late presentation and nonspecific symptoms. Despite diagnostic and procedural challenges highlighted in this case, early surgical intervention and comprehensive follow-up are essential for achieving favorable outcomes and minimizing recurrence risks in patients with small bowel NETs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    由无线胶囊内窥镜捕获的大量帧涉及不同量的气泡。尽管不同的研究认为气泡是无用的药物,因为它们会降低小肠粘膜的可视化质量,这项研究旨在开发一种评估圆形气泡流变能力的实用方法,作为未来临床诊断的建议。
    来自Kvasir胶囊内窥镜检查数据集,根据气泡大小,将气泡参与程度不同的帧分为两类。边界反射存在于其边界中圆形气泡的边缘上,在频域中,高频带对应于空间域中的这些边缘。第一步是使用小波变换(WT)和高斯差分对边界反射进行高通滤波,第二步涉及在提取的边界上应用快速Circlet变换(FCT)和Hough变换作为圆检测工具,并评估具有半径变化的所有气泡的分布和丰度。
    使用WT作为预处理方法的Border\的提取使圆形检测工具更容易专注于高频圆形图案。因此,应用具有预定义参数的FCT可以指定图像中所有气泡的半径和丰度的种类和范围。总辨别因子(ODF)为15.01和7.1,显示在胃肠(GI)道中不同的气泡分布。来自数据集1-2的ODF的区别表明,气泡的流变特性与其覆盖面积及其丰度之间存在关系。突出显示WT和FCT在确定诊断目标气泡分布方面的性能。
    在胃肠道分析中实施面向对象的态度使胃肠病学家可以理解,以近似肠内液体的构成特征。这不能被评估,直到气泡被认为是无用的代理。从数据集获得的结果证明,计算的ODF之间的差异可以用作评估肠内流体的质量的指标,如粘度,这有助于胃肠病学家评估患者的消化质量。
    UNASSIGNED: A significant number of frames captured by the wireless capsule endoscopy are involved with varying amounts of bubbles. Whereas different studies have considered bubbles as nonuseful agents due to the fact that they reduce the visualization quality of the small intestine mucosa, this research aims to develop a practical way of assessing the rheological capability of the circular bubbles as a suggestion for future clinical diagnostic purposes.
    UNASSIGNED: From the Kvasir-capsule endoscopy dataset, frames with varying levels of bubble engagements were chosen in two categories based on bubble size. Border reflections are present on the edges of round-shaped bubbles in their boundaries, and in the frequency domain, high-frequency bands correspond to these edges in the spatial domain. The first step is about high-pass filtering of border reflections using wavelet transform (WT) and Differential of Gaussian, and the second step is related to applying the Fast Circlet Transform (FCT) and the Hough transform as circle detection tools on extracted borders and evaluating the distribution and abundance of all bubbles with the variety of radii.
    UNASSIGNED: Border\'s extraction using WT as a preprocessing approach makes it easier for circle detection tool for better concentration on high-frequency circular patterns. Consequently, applying FCT with predefined parameters can specify the variety and range of radius and the abundance for all bubbles in an image. The overall discrimination factor (ODF) of 15.01, and 7.1 showing distinct bubble distributions in the gastrointestinal (GI) tract. The discrimination in ODF from datasets 1-2 suggests a relationship between the rheological properties of bubbles and their coverage area plus their abundance, highlighting the WT and FCT performance in determining bubbles\' distributions for diagnostic objectives.
    UNASSIGNED: The implementation of an object-oriented attitude in gastrointestinal analysis makes it intelligible for gastroenterologists to approximate the constituent features of intra-intestinal fluids. this can\'t be evaluated until the bubbles are considered as non-useful agents. The obtained results from the datasets proved that the difference between the calculated ODF can be used as an indicator for the quality estimation of intraintestinal fluids\' rheological features like viscosity, which helps gastroenterologists evaluate the quality of patient digestion.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:临床护理路径有助于为临床医生和提供者提供指导和结构,以改善医疗保健服务和质量。美国代谢和减肥外科学会(ASMBS)的质量改进和患者安全委员会(QIPS)先前已发布了有关腹腔镜袖状胃切除术(LSG)和Roux-en-Y胃旁路术(RYGB)患者术前护理的护理途径。
    目的:当前的RYGB护理路径旨在解决术中护理问题,定义为在手术当天从术前保持区域进行的护理,穿过手术室,并进入麻醉后监护室(PACU)。
    方法:PubMed查询于2001年1月至2019年12月进行,并根据委员会提出的具体关键问题的证据级别进行审查。
    结果:为接受RYGB的患者提供了循证建议,包括术前保持区域,RYGB的术中管理和性能,和并行程序。
    结论:本文件可以根据最近的证据为减肥外科医生和提供者提供微创RYGB的术中护理提供指导。
    BACKGROUND: Clinical care pathways help guide and provide structure to clinicians and providers to improve healthcare delivery and quality. The Quality Improvement and Patient Safety Committee (QIPS) of the American Society for Metabolic and Bariatric Surgery (ASMBS) has previously published care pathways for the performance of laparoscopic sleeve gastrectomy (LSG) and pre-operative care of patients undergoing Roux-en-Y gastric bypass (RYGB).
    OBJECTIVE: This current RYGB care pathway was created to address intraoperative care, defined as care occurring on the day of surgery from the preoperative holding area, through the operating room, and into the postanesthesia care unit (PACU).
    METHODS: PubMed queries were performed from January 2001 to December 2019 and reviewed according to Level of Evidence regarding specific key questions developed by the committee.
    RESULTS: Evidence-based recommendations are made for care of patients undergoing RYGB including the pre-operative holding area, intra-operative management and performance of RYGB, and concurrent procedures.
    CONCLUSIONS: This document may provide guidance based on recent evidence to bariatric surgeons and providers for the intra-operative care for minimally invasive RYGB.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    背景:小肠血管瘤很少见,通常存在于年轻人中。术前诊断非常困难。我们报告了一例罕见的小儿混合肠血管瘤(IH)引起肠套叠的病例。
    方法:一个3个月大的女孩,没有病史或手术史,因间歇性腹痛导致直肠出血和阵发性哭闹。紧急腹部超声显示回肠肠套叠。手术结果证实了肠套叠,并对肠套叠空肠进行了节段性切除术。组织病理学检查发现混合性血管瘤。术后病程顺利。
    结论:临床表现可能包括肠出血导致贫血,阻塞,肠套叠和穿孔。由小肠血管瘤引起的肠套叠极为罕见。值得注意的是,我们没有发现任何儿童肠套叠显示的小肠血管瘤病例。血管瘤的主要治疗方法是手术切除受影响的节段。文献中没有关于血管瘤术后复发的证据。
    结论:继发于肠血管瘤的肠套叠极为罕见。术前诊断具有挑战性,因为传统技术通常无法检测到它们。增强对这种情况的认识和理解可以促进早期诊断并改善管理结果。
    BACKGROUND: Hemangiomas of the small intestine are rare and usually present in young people. They are very difficult to diagnose preoperatively. We report a rare case of mixed intestinal hemangioma (IH) causing intussusception in a pediatric patient.
    METHODS: A 3-month-old girl, with no prior medical or surgical history, was admitted with rectal bleeding and paroxysmal crying due to intermittent abdominal pain. An urgent abdominal ultrasound revealed ileo-ileal intussusception. Operative findings confirmed the intussusception, and a segmental resection of the intussuscepted jejunum was performed. Histopathological examination found a mixed hemangioma. The postoperative course was uneventful.
    CONCLUSIONS: Clinical presentation may include intestinal bleeding leading to anemia, obstruction, intussusception and perforation. Intussusception caused by small bowel hemangioma is extremely rare. Notably, we didn\'t find any cases of small bowel hemangioma revealed by intussusception in children. The main treatment for hemangiomas is surgical resection of the affected segment. No evidence in the literature on postoperative recurrence of hemangiomas.
    CONCLUSIONS: Intussusception secondary to intestinal hemangiomas is extremely rare. Preoperative diagnosis is challenging as they are often undetectable with traditional techniques. Enhanced awareness and understanding of this condition can facilitate earlier diagnosis and improve management outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    一名46岁的男子在厕所紧张后出现小肠脱出肛门,开始成为缺血性疾病。他承认在拉伤前约半小时将一个塑料物体插入直肠。通过将具有盐水的静脉滴注管线滴到湿拭子上,使肠保持湿润。在剧院,发现肠通过上直肠的一个孔脱出,并通过肛门脱出。它通过同样的穿孔减少到腹腔,长4厘米,不需要延长它。用聚二恶烷酮(PDS)2-0缝合,因为没有粪便或脓液污染。由于小肠外观的改善和肠系膜的严重瘀伤,计划在24小时内重新审视。重新看小肠看起来很健康,因此没有进行切除.然而,环形结肠造口术是为了保护上直肠穿孔修复术。这表明在这种情况下并不总是需要切除。
    A 46-year-old man presented with a small bowel prolapsing through the anus after straining on the toilet, which was starting to become ischaemic. He admitted to inserting a plastic object in his rectum about half an hour before straining. The bowel was kept moist by placing an intravenous drip line with saline dripping onto a wet swab. In theatre, the bowel was found to be prolapsing through a hole in the upper rectum and out through the anus. It was reduced back into the abdominal cavity through the same perforation, which was 4 cm long, without needing to extend it. This was sutured with polydioxanone (PDS) 2-0 as there was no contamination with faeces or pus. Due to improvement in the appearance of a small bowel and an extremely bruised mesentery, a re-look was planned in 24 hours. At the re-look the small bowel appeared healthy, therefore no resection was performed. However, a loop colostomy was fashioned to protect the upper rectal perforation repair. This shows that resection is not always required in such cases.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:据报道,与其他CD表型相比,孤立的小肠克罗恩病(SBCD)的预后较差。这项研究的目的是了解分离的SBCD和回肠结肠疾病与血液和粪便生物标志物之间的相关性,并确定两种表型之间的结果和管理差异。
    方法:从现有的胶囊内镜(CE)数据库中确定了回肠结肠或孤立性小肠克罗恩病(SBCD)患者。哈维·布拉德肖指数(HBI),生物标志物:C反应蛋白(CRP)和粪便钙卫蛋白(FC),收集Lewis评分和CE的发现以及随后的随访数据。采用SPSS进行数据分析。
    结果:共248例患者纳入研究。将患者分为两组:分离的SBCD患者178例(中位年龄44岁(IQR31-56);男性占41.5%),结肠克罗恩病患者70例(中位年龄31岁(IQR22.7-49);男性占31.5%)。新诊断为SBCD的占38.7%(n=96),而60.0%(n=144)已建立CD。与孤立的SBCD相比,回肠结肠疾病患者的HBI较高[HBI=7(IQR5-10)vsHBI=6(IQR4-9);P=0.04]。分离的SBCD和回肠结肠疾病之间的FC水平没有显着差异[136ug/g(IQR53.8-363.3)与171ug/g(IQR68.5-485.5);p=0.98]。在孤立的SBCD组中,30.3%(n=54)CE显示近端疾病,96%(n=171)显示远端疾病,26.4%(n=47)显示广泛疾病。SBCE诊断近端SBCD优于MRI(P<0.01)。在多元逻辑回归中,我们没有发现任何定义为Lewis评分>790的疾病严重程度预测因子.在SBCE之后,68.5%(n=170)的患者有管理变更。这包括123例(49.5%)患者开始使用皮质类固醇或剂量递增,硫唑嘌呤在80例(33.3%)患者中,甲氨蝶呤治疗22例(9.1%),生物治疗110例(44.3%)。HBI预测了管理的变化(p<0.01)。
    结论:CE是诊断活动性SBCD的重要方法。它还有助于指导确定患有活动性疾病的患者的治疗。
    OBJECTIVE: Isolated small bowel Crohn\'s disease (SBCD) is reported to have a worse prognosis compared to other CD phenotypes. The aim of this study was to understand the correlation between Isolated SBCD and ileocolonic disease with blood and faecal biomarkers and also to identify differences in outcome and management between the two phenotypes.
    METHODS: Patients with ileocolonic or isolated small bowel Crohn\'s Disease (SBCD) were identified from an existing capsule endoscopy (CE) database. Harvey Bradshaw Index (HBI), biomarkers: c-reactive protein (CRP) and faecal calprotectin (FC), Lewis score and findings on CE and subsequent follow up data were collected. SPSS was used to analyse the data.
    RESULTS: In total 248 patients were included in the study. Patients were split into two groups- Isolated SBCD with 178 patient (median age 44 years (IQR 31-56); 41.5 % male) and Ileocolonic Crohn\'s with 70 patients (median age 31 years (IQR 22.7-49); 31.5 % male). A new diagnosis of SBCD was made in 38.7 % (n = 96), whilst 60.0 % (n = 144) had established CD. Patients with ileocolonic disease had a higher HBI in comparison to isolated SBCD [HBI = 7 (IQR 5-10) vs HBI = 6(IQR 4-9); P = 0.04 ]. There was no significant difference in the FC levels between isolated SBCD and ileocolonic disease [136ug/g (IQR 53.8-363.3) vs 171ug/g (IQR 68.5-485.5); p = 0.98]. In isolated SBCD group, 30.3 % (n = 54) CE showed proximal disease, 96 % (n = 171) showed distal disease and 26.4 % (n = 47) showed extensive disease. SBCE was superior to MRI at diagnosing proximal SBCD (P < 0.01). On multivariate logistic regression, we did not identify any predictors of disease severity defined as Lewis score > 790. Following SBCE, 68.5 % (n = 170) of the total patients had a management change. This included commencement or dose escalation of corticosteroids in 123 (49.5 %) patients, azathioprine in 80 (33.3 %) patients, methotrexate in 22 (9.1 %) patients and biological therapy in 110 (44.3 %) patients. HBI predicted a change in management (p < 0.01).
    CONCLUSIONS: CE is an important modality for the diagnosis of active SBCD. It also helps guide treatment in patients identified with active disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    我们先前显示了肠易激综合征(IBS)患者应用结肠粘膜活检上清液后的肠神经激活。问题仍然是这是针对特定区域的还是普遍的敏感化。我们测试了IBS腹泻患者(IBS-D)的大肠和小肠区域上清液的神经激活特性,与肥大细胞增多症患者腹泻(MC-D)或非IBS/非MC患者的神经激活特性-投诉。MC-D患者被纳入到来自已确定的患者的测试样本中,严重的肥大细胞疾病,因为建议肥大细胞在IBS中起作用。
    使用电压敏感染料成像记录来自IBS-D的粘膜活检上清液的影响,MC-D,和非IBS/非MC对豚鼠粘膜下神经元的影响。在所有样品中测量肥大细胞密度和组胺浓度。
    IBS-D(十二指肠和结肠,近端和远端,分别为49.3;50.5;63.7;71.9)与非IBS/非MC(十二指肠和结肠,近端和远端,8.7;4.9;6.9;5.4)或MC-D上清液(十二指肠和结肠,近端和远端,9.4;11.9;0.0;7.9)。MC-D和非IBS/非MC上清液的神经激活是相当的(p>0.05)。肥大细胞密度或组胺浓度在IBS-D之间没有差异,MC-D,和非IBS/非MC样品。
    活检上清液激活神经是IBS的标志,发生在整个肠道,与肥大细胞密度或组胺浓度无关。至少同样重要的是我们的发现,胃肠道主诉本身与活检上清液诱导的神经激活无关,这进一步强调了IBS中神经行为改变的相关性。
    UNASSIGNED: We previously showed enteric nerve activation after application of colonic mucosal biopsy supernatants from patients with irritable bowel syndrome (IBS). The question remains whether this is a region-specific or a generalized sensitization. We tested the nerve-activating properties of supernatants from large and small intestinal regions of IBS patients with diarrhea (IBS-D) in comparison to those from mastocytosis patients with diarrhea (MC-D) or non-IBS/non-MC patients with GI-complaints. MC-D patients were included to test samples from patients with an established, severe mast cell disorder, because mast cells are suggested to play a role in IBS.
    UNASSIGNED: Voltage-sensitive dye imaging was used to record the effects of mucosal biopsy supernatants from IBS-D, MC-D, and non-IBS/non-MC on guinea pig submucous neurons. Mast cell density and histamine concentrations were measured in all samples.
    UNASSIGNED: The median neuroindex (spike frequency × % responding neurons in Hz × %) was significantly (all p < 0.001) increased for IBS-D (duodenum and colon, proximal and distal each, 49.3; 50.5; 63.7; 71.9, respectively) compared to non-IBS/non-MC (duodenum and colon, proximal and distal each, 8.7; 4.9; 6.9; 5.4, respectively) or MC-D supernatants (duodenum and colon, proximal and distal each, 9.4; 11.9; 0.0; 7.9, respectively). Nerve activation by MC-D and non-IBS/non-MC supernatants was comparable (p>0.05). Mast cell density or histamine concentrations were not different between IBS-D, MC-D, and non-IBS/non-MC samples.
    UNASSIGNED: Nerve activation by biopsy supernatants is an IBS hallmark that occurs throughout the gut, unrelated to mast cell density or histamine concentration. At least as important is our finding that GI complaints per se were not associated with biopsy supernatant-induced nerve activation, which further stresses the relevance of altered nerve behavior in IBS.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号